Holen Sie sich die Stockscreener-App
0.63
1.61%
0.01
Handel nachbörslich:
.62
-0.01
-1.59%
Schlusskurs vom Vortag:
$0.62
Offen:
$0.632
24-Stunden-Volumen:
26,548
Relative Volume:
0.80
Marktkapitalisierung:
$18.03M
Einnahmen:
$1.13M
Nettoeinkommen (Verlust:
$-20.74M
KGV:
-0.3351
EPS:
-1.88
Netto-Cashflow:
$-18.37M
1W Leistung:
+8.64%
1M Leistung:
-11.12%
6M Leistung:
-47.50%
1J Leistung:
-62.50%
1-Tages-Spanne:
$0.60
$0.632
1-Wochen-Bereich:
$0.57
$0.6621
52-Wochen-Spanne:
$0.57
$2.115
Cyclo Therapeutics Inc Stock (CYTH) Company Profile
Firmenname
Cyclo Therapeutics Inc
Sektor
Telefon
386-418-8060
Adresse
6714 NW 16TH STREET, SUITE B, GAINESVILLE
Vergleichen Sie CYTH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CYTH
Cyclo Therapeutics Inc
|
0.63 | 18.03M | 1.13M | -20.74M | -18.37M | -0.88 |
|
ZTS
Zoetis Inc
|
164.84 | 74.37B | 9.15B | 2.43B | 2.31B | 5.32 |
|
HLN
Haleon Plc Adr
|
9.69 | 43.81B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.10 | 41.53B | 30.27B | 1.93B | 3.45B | 0.6044 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
22.09 | 25.03B | 16.77B | -959.00M | 1.37B | -0.85 |
|
VTRS
Viatris Inc
|
12.52 | 14.94B | 15.05B | -883.30M | 1.89B | -0.74 |
Cyclo Therapeutics Inc Aktie (CYTH) Neueste Nachrichten
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LTRPA, LTRPB, CYTH, SKGR on Behalf of Shareholders - Benzinga
$TOCKHOLDER ALERT: The M&A Class Action Firm Continues To Investigate MergerZUO, CYTH, PDCO, SKGR - cnhinews.com
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates - GlobeNewswire
SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Cyclo Therapeutics, Inc.CYTH - The Eastern Progress Online
$HAREHOLDER ALERT: The M&A Class Action Continues To Investigate MergerAE, ZUO, CYTH, EMKR - The Eastern Progress Online
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ARCH, CYTH, VGR on Behalf of Shareholders - The Eastern Progress Online
CYTH Stock Plummets to 52-Week Low of $0.59 Amid Market Challenges - Investing.com Canada
CYTH Stock Plummets to 52-Week Low of $0.59 Amid Market Challenges By Investing.com - Investing.com South Africa
Rafael Holdings: Strategic Developments and Financial Insights - TipRanks
Rafael Holdings Reports First Quarter Fiscal 2025 Financial Results - The Manila Times
Rafael Holdings Reports Widening Losses Ahead of Strategic Cyclo Therapeutics Merger - StockTitan
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ENLC, ALVR, CYTH on Behalf of Shareholders - GlobeNewswire
SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Continues to Investigate the Mergers of CYTH, NAPA, MNTX and MARX - The Eastern Progress Online
Kuehn Law Encourages RVNC, RFL, BTTR, and ARC Investors to Contact Law Firm - The Eastern Progress Online
Kuehn Law Encourages COFS, ARC, RFL, and NBY Investors to Contact Law Firm - The Eastern Progress Online
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CYTH, BRKH, PIRS, CFB on Behalf of Shareholders - The Eastern Progress Online
$HAREHOLDER INVESTIGATION: The M&A Class Action Firm Continues to Investigate the Mergers of CYTH, VBFC, CFB and MKFG - The Eastern Progress Online
$HAREHOLDER INVESTIGATION: The M&A Class Action Firm Continues to Investigate the Mergers of BFAC, BCOV, CYTH and ARCH - The Eastern Progress Online
STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Investigates the Merger of Sterling Bancorp, Inc.- SBT - The Eastern Progress Online
SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Poseida Therapeutics, Inc.PSTX - The Eastern Progress Online
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates USAP, CYTH, ARCH on Behalf of Shareholders - GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MNTX, ARCH, CYTH on Behalf of Shareholders - Morningstar
CYTH (Cyclo Therapeutics) 3-Year Revenue Growth Rate : -51.10% (As of Sep. 2024) - GuruFocus.com
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MNTX, CFB, ARCH, CYTH on Behalf of Shareholders - Morningstar
Cyclo Therapeutics, Inc. (CYTH) Reports Q3 Loss, Lags Revenue Estimates - MSN
SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Continues to Investigate the Mergers of MKFG, CYTH, BRKH and CFB - cnhinews.com
Finansavisen - Finansavisen
SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Piedmont Lithium Inc.PLL - Longview News-Journal
Eloxx Pharmaceuticals (NASDAQ:ELOX) and Cyclo Therapeutics (NASDAQ:CYTH) Financial Survey - Defense World
TeleChoice International’s Path to Exiting SGX Watch-list - MSN
Cyclo Therapeutics Inc (CYTH) Quarterly 10-Q Report - Quartzy
Cyclo Therapeutics Completes Phase 3 Trial Enrollment, Plans 2025 NDA Filing Amid Merger | CYTH Stock News - StockTitan
Well Health Stock: Buy, Sell, or Hold? - MSN
Canopy Growth (CGC) Stock Dives Amid Financial Struggles and Ind - GuruFocus.com
AMGN Stock Drops 5% Amid Industry Decline and Earnings Report - GuruFocus.com
Siga Technologies (SIGA) Sees Significant Stock Decline Amidst P - GuruFocus.com
Niemann-Pick Disease Type C Pipeline 2024: Clinical Trials - openPR
Astrazeneca: How a fraud investigation crashed a FTSE 100 giant - MSN
Rafael Holdings Inc. Class B (RFL) Annual 10-K Report - Quartzy
Finanzdaten der Cyclo Therapeutics Inc-Aktie (CYTH)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.61%
1.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):